장기 보존액 시장 보고서(2026년)
Organ Preservation Solution Global Market Report 2026
상품코드 : 1927061
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,655,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,619,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,583,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

장기 보존액 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 3억 1,000만 달러에서 2026년에는 3억 3,000만 달러에 이르고, CAGR 6.7%로 확대가 전망됩니다. 지난 수년간의 성장 요인으로는 장기이식 수술 건수 증가, 이식 인프라 확충, 보존액 가용성 향상, 저온 보존 기술 보급, 의료 보존 화학의 발전 등을 꼽을 수 있습니다.

장기 보존액 시장 규모는 향후 몇 년간에 강력한 성장이 전망됩니다. 2030년에는 6.8%의 연평균 복합 성장률(CAGR)로 4억 3,000만 달러에 이를 전망입니다. 예측 기간의 성장 요인으로는 장기 이식 수요 증가, 첨단 보존 기술의 보급 확대, 기계 관류 시스템의 확대, 이식 성공률에 대한 관심 증가, 장기 보호 제제의 혁신 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 허혈 재관류 장애 완화 기술의 발전, 기계 관류 기술의 보급 확대, 다장기 보존액 사용 증가, 이식 보존 기간 연장, 장기 생존율에 대한 관심 증가 등을 꼽을 수 있습니다.

의료비 지출 증가가 장기 보존액 시장의 성장을 견인하고 있습니다. 의료비 지출은 특정 지역, 국가, 조직 내에서 의료 분야에 할당되는 총 자금을 의미합니다. 장기 보존액은 운송 및 보관 중인 장기를 보존하고 생존성을 확보하여 이식 수술의 성공률을 높이는데 필수적인 역할을 합니다. 이러한 솔루션에 대한 투자는 이식 결과 개선에 기여하고 합병증 및 관련 의료비 절감으로 이어질 수 있습니다. 예를 들어, 캐나다 보건정보연구소(CIHI)에 따르면, 2023년 11월 기준 캐나다의 총 의료비는 3,440억 캐나다 달러(1인당 8,740 캐나다 달러)에 달할 것으로 예측됩니다. 이는 2022년 1.5% 증가에서 2.8% 증가로 뚜렷한 회복세를 보이고 있으며, 의료 투자가 크게 증가했음을 알 수 있습니다. 따라서 의료비 증가는 향후 장기 보존액 시장의 성장을 견인하는 요인이 될 것입니다.

제품 혁신은 장기 보존액 시장에서 점점 더 활발해지고 있는 중요한 트렌드입니다. 이 분야의 주요 기업들은 자사의 입지를 강화하고 경쟁 우위를 확보하기 위해 최첨단 제품 개발에 주력하고 있습니다. 예를 들어, 2024년 6월 미국 장기 보존 기술 전문 기업 파라고닉스 테크놀로지스(Paragonix Technologies)는 'PancreasPak 장기 보존 시스템'을 발표했습니다. 이 장치는 운송 중 기증자의 췌장을 보호하고 모니터링하기 위해 특별히 설계된 최초의 FDA 승인 제품으로 장기 이식에서 중요한 역할을 강조하고 있습니다. 본 시스템은 췌장을 4-8℃의 최적 온도 범위로 유지하는 제어 환경을 구축합니다. 이는 최대 21시간에 이르는 운송 중 장기의 생존율과 기능을 유지하는 데 필수적입니다. 또한 'PancreasPak'은 디지털 모니터링 기능을 통해 췌장의 온도와 주변 환경을 지속적으로 추적합니다. 이 실시간 데이터를 통해 최적의 조건에서 벗어난 상황에 즉각적으로 대응할 수 있어 장기 보존의 질을 향상시킬 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문 목차

영문목차

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the organ preservation solution market by increasing costs of imported pharmaceutical ingredients, sterile packaging materials, cold-chain equipment, and perfusion system components. Transplant centers in North America and Europe are most affected due to reliance on imported solutions, while Asia-Pacific faces higher costs for advanced preservation technologies. These tariffs are increasing procurement costs for healthcare providers. However, they are also encouraging local manufacturing, regional supply chain development, and innovation in cost-effective preservation solutions.

The organ preservation solution market research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including organ preservation solution industry global market size, regional shares, competitors with a organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organ preservation solution market size has grown strongly in recent years. It will grow from $0.31 billion in 2025 to $0.33 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growth of organ transplantation procedures, expansion of transplant infrastructure, increasing availability of preservation solutions, adoption of cold storage techniques, advancements in medical preservation chemistry.

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing organ transplant demand, rising adoption of advanced preservation technologies, expansion of machine perfusion systems, growing focus on transplant success rates, innovation in organ protection formulations. Major trends in the forecast period include advancements in ischemia-reperfusion injury mitigation, rising adoption of machine perfusion techniques, growing use of multi-organ preservation solutions, expansion of transplant storage durations, enhanced focus on organ viability.

The increase in healthcare spending is driving the growth of the organ preservation solution market. Healthcare spending refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Organ preservation solutions are critical in optimizing the success of organ transplantation procedures, as they preserve organs during transportation and storage to ensure viability. Investment in these solutions contributes to improved transplant outcomes, reducing complications and associated healthcare costs. For instance, in November 2023, according to the Canadian Institute for Health Information, total health spending in Canada was projected to reach $344 billion, or $8,740 per person. This represents a 2.8% increase compared to the 1.5% growth in 2022, indicating a notable rebound in healthcare investment. Therefore, the increase in healthcare spending is propelling the growth of the organ preservation solution market going forward.

Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.

In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.

Major companies operating in the organ preservation solution market are Bridge to Life, XVIVO Perfusion, Organ Recovery Systems, Dr. Franz Kohler Chemie, BioLife Solutions, Essential Pharmaceuticals, Preservation Solutions, KPS Life, Hibernicor, Advanced Organ Biosciences, Paragonix Technologies, TransMedics, OrganOx, Organ Assist, XVIVO Lung Perfusion, Cell and Tissue Systems, Sustained Medical, Organ Preservation Alliance, Lifeline Scientific, Arthrex

North America was the largest region in the organ preservation solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organ Preservation Solution Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Organ Preservation Solution Market Characteristics

3. Organ Preservation Solution Market Supply Chain Analysis

4. Global Organ Preservation Solution Market Trends And Strategies

5. Organ Preservation Solution Market Analysis Of End Use Industries

6. Organ Preservation Solution Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Organ Preservation Solution Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Organ Preservation Solution Total Addressable Market (TAM) Analysis for the Market

9. Organ Preservation Solution Market Segmentation

10. Organ Preservation Solution Market Regional And Country Analysis

11. Asia-Pacific Organ Preservation Solution Market

12. China Organ Preservation Solution Market

13. India Organ Preservation Solution Market

14. Japan Organ Preservation Solution Market

15. Australia Organ Preservation Solution Market

16. Indonesia Organ Preservation Solution Market

17. South Korea Organ Preservation Solution Market

18. Taiwan Organ Preservation Solution Market

19. South East Asia Organ Preservation Solution Market

20. Western Europe Organ Preservation Solution Market

21. UK Organ Preservation Solution Market

22. Germany Organ Preservation Solution Market

23. France Organ Preservation Solution Market

24. Italy Organ Preservation Solution Market

25. Spain Organ Preservation Solution Market

26. Eastern Europe Organ Preservation Solution Market

27. Russia Organ Preservation Solution Market

28. North America Organ Preservation Solution Market

29. USA Organ Preservation Solution Market

30. Canada Organ Preservation Solution Market

31. South America Organ Preservation Solution Market

32. Brazil Organ Preservation Solution Market

33. Middle East Organ Preservation Solution Market

34. Africa Organ Preservation Solution Market

35. Organ Preservation Solution Market Regulatory and Investment Landscape

36. Organ Preservation Solution Market Competitive Landscape And Company Profiles

37. Organ Preservation Solution Market Other Major And Innovative Companies

38. Global Organ Preservation Solution Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Organ Preservation Solution Market

40. Organ Preservation Solution Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기